Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic.

Fraguas-Sánchez, Ana Isabel; Lozza, Irene; Torres-Suárez, Ana Isabel

Fraguas-Sánchez, Ana Isabel; Lozza, Irene; Torres-Suárez, Ana Isabel.

Afiliação

Fraguas-Sánchez AI; Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.
Lozza I; Institute of Industrial Pharmacy, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.
Torres-Suárez AI; Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.

Cancers (Basel) ; 14(5)2022 Feb 25.

Article em En | MEDLINE | ID: mdl-35267507

Palavras-chave

HER-2 receptors; TNBC; active targeting; albumin nanoparticles; antibodydrug conjugates; ephrin receptors; liposomes; nanomedicine; trastuzumab; trop-2 glycoprotein

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google